tiprankstipranks
Advertisement
Advertisement

DE:PHE Stock Latest News

Cipher Pharmaceuticals Balances U.S. Strain With Epuris Strength
Company AnnouncementsCipher Pharmaceuticals Balances U.S. Strain With Epuris Strength
6d ago
Cipher Pharmaceuticals price target lowered to C$20 from C$22 at Stifel
PremiumThe Fly
Cipher Pharmaceuticals price target lowered to C$20 from C$22 at Stifel
12d ago
Cipher Pharmaceuticals Balances Q2 Earnings Dip With Epuris Growth and Strong Balance Sheet
PremiumCompany Announcements
Cipher Pharmaceuticals Balances Q2 Earnings Dip With Epuris Growth and Strong Balance Sheet
17d ago
Is CPHRF a Buy, Before Earnings?
PremiumPre-Earnings
Is CPHRF a Buy, Before Earnings?
20d ago
Cipher Pharmaceuticals price target raised to C$22 from C$21 at Stifel
PremiumThe Fly
Cipher Pharmaceuticals price target raised to C$22 from C$21 at Stifel
4M ago
CaryHealth launches direct-to-patient program for Cipher’s Natroba
PremiumThe FlyCaryHealth launches direct-to-patient program for Cipher’s Natroba
5M ago
Cipher Pharmaceuticals price target raised to C$21 from C$20 at Stifel
Premium
The Fly
Cipher Pharmaceuticals price target raised to C$21 from C$20 at Stifel
6M ago
Cipher Pharmaceuticals Delivers Record 2025 Results and Primes for Next Acquisition Phase
Premium
Company Announcements
Cipher Pharmaceuticals Delivers Record 2025 Results and Primes for Next Acquisition Phase
6M ago
Is CPHRF a Buy, Before Earnings?
PremiumPre-Earnings
Is CPHRF a Buy, Before Earnings?
6M ago
Cipher Pharmaceuticals Sets March Date for Q4 and Fiscal 2025 Results
PremiumCompany Announcements
Cipher Pharmaceuticals Sets March Date for Q4 and Fiscal 2025 Results
6M ago
Cipher Wins Health Canada Review for Natroba Head Lice and Scabies Treatment
PremiumCompany Announcements
Cipher Wins Health Canada Review for Natroba Head Lice and Scabies Treatment
7M ago
Cipher Pharmaceuticals: Strong Q3 2025 Earnings Call
PremiumCompany Announcements
Cipher Pharmaceuticals: Strong Q3 2025 Earnings Call
10M ago
Cipher Pharmaceuticals Reports Strong Q3 2025 Results
PremiumCompany AnnouncementsCipher Pharmaceuticals Reports Strong Q3 2025 Results
10M ago
Cipher Pharmaceuticals Reports Strong Q3 2025 Financial Results
Premium
Company Announcements
Cipher Pharmaceuticals Reports Strong Q3 2025 Financial Results
10M ago
Cipher Pharmaceuticals Achieves Strong Q3 2025 Financial Performance
Premium
Company Announcements
Cipher Pharmaceuticals Achieves Strong Q3 2025 Financial Performance
10M ago
Cipher Pharmaceuticals Inc (CPHRF) Q3 Earnings Cheat Sheet
PremiumPre-Earnings
Cipher Pharmaceuticals Inc (CPHRF) Q3 Earnings Cheat Sheet
10M ago
Cipher Pharmaceuticals to Announce Q3 2025 Financial Results
PremiumCompany Announcements
Cipher Pharmaceuticals to Announce Q3 2025 Financial Results
10M ago
Cipher Pharmaceuticals Wins Arbitration Against Sun Pharmaceuticals
PremiumCompany Announcements
Cipher Pharmaceuticals Wins Arbitration Against Sun Pharmaceuticals
11M ago
Cipher Pharmaceuticals Mourns the Loss of Esteemed Board Member Harold Wolkin
PremiumCompany Announcements
Cipher Pharmaceuticals Mourns the Loss of Esteemed Board Member Harold Wolkin
1y ago
Cipher Pharmaceuticals’ Record Earnings Driven by Natroba
PremiumCompany AnnouncementsCipher Pharmaceuticals’ Record Earnings Driven by Natroba
1y ago
Cipher Pharmaceuticals price target raised to C$20 from C$17 at Stifel
Premium
The Fly
Cipher Pharmaceuticals price target raised to C$20 from C$17 at Stifel
1y ago
Cipher Pharmaceuticals price target raised to C$14 from C$13 at Canaccord
Premium
The Fly
Cipher Pharmaceuticals price target raised to C$14 from C$13 at Canaccord
1y ago

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >